Dionisio Zaldivar Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Dionisio Zaldivar Silva has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Lissette Agüero
USST-UH International Joint Laboratory for Tumor Diagnosis and Energy Treatment, University of Shanghai for Science and Technology, Shanghai 200093, China
2 shared publications - Baolin Liu
University of Shanghai for Science and Technology
1 shared publication - Cristiane Gimenes de Souza
Petroleum and Biofuels Chemistry Program PRH 20.1, Instituto de Química, Universidade Federal do Rio de Janeiro, Cidade Universitária, Brasil
1 shared publication - Edson Rodrigo Fernandes dos Santos
Centro de Tecnologia, COPPE, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication L. A. D´aVila
Laboratório de Biocombustíveis, Escola de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication- Leonardo Rodrigues Andrade
Waitt Advanced Biophotonics Center, Salk Institute for Biological Studies, La Jolla, USA
1 shared publication
Latest Publications
- Open Access
Recent Development of Rhenium-Based Materials in the Application of Diagnosis and Tumor Therapy
Rhenium (Re) is widely used in the diagnosis and treatment of cancer due to its unique physical and chemical properties. Re has more valence electrons in its outer shell, allowing it to exist in a variety of oxidation states and to form different geometric configurations with many different ligands. The luminescence properties, lipophilicity, and cytotoxicity of complexes can be adjusted by changing the ligand of Re. This article mainly reviews the development of radionuclide 188Re in radiotherapy and some innovative applications of Re as well as the different therapeutic approaches and imaging techniques used in cancer therapy. In addition, the current application and future challenges and opportunities of Re are also discussed.
Open AccessRecent Development of Rhenium-Based Materials in the Application of Diagnosis and Tumor Therapy
Rhenium (Re) is widely used in the diagnosis and treatment of cancer due to its unique physical and chemical properties. Re has more valence electrons in its outer shell, allowing it to exist in a variety of oxidation states and to form different geometric configurations with many different ligands. The luminescence properties, lipophilicity, and cytotoxicity of complexes can be adjusted by changing the ligand of Re. This article mainly reviews the development of radionuclide 188Re in radiotherapy and some innovative applications of Re as well as the different therapeutic approaches and imaging techniques used in cancer therapy. In addition, the current application and future challenges and opportunities of Re are also discussed.
- Top Cited PapersOpen Access
Chitosan-Based Hemostatic Hydrogels: The Concept, Mechanism, Application, and Prospects
The design of new hemostatic materials to mitigate uncontrolled bleeding in emergencies is challenging. Chitosan-based hemostatic hydrogels have frequently been used for hemostasis due to their unique biocompatibility, tunable mechanical properties, injectability, and ease of handling. Moreover, chitosan (CS) absorbs red blood cells and activates platelets to promote hemostasis. Benefiting from these desired properties, the hemostatic application of CS hydrogels is attracting ever-increasing research attention. This paper reviews the recent research progress of CS-based hemostatic hydrogels and their advantageous characteristics compared to traditional hemostatic materials. The effects of the hemostatic mechanism, effects of deacetylation degree, relative molecular mass, and chemical modification on the hemostatic performance of CS hydrogels are summarized. Meanwhile, some typical applications of CS hydrogels are introduced to provide references for the preparation of efficient hemostatic hydrogels. Finally, the future perspectives of CS-based hemostatic hydrogels are presented.
Top Cited PapersOpen AccessChitosan-Based Hemostatic Hydrogels: The Concept, Mechanism, Application, and Prospects
The design of new hemostatic materials to mitigate uncontrolled bleeding in emergencies is challenging. Chitosan-based hemostatic hydrogels have frequently been used for hemostasis due to their unique biocompatibility, tunable mechanical properties, injectability, and ease of handling. Moreover, chitosan (CS) absorbs red blood cells and activates platelets to promote hemostasis. Benefiting from these desired properties, the hemostatic application of CS hydrogels is attracting ever-increasing research attention. This paper reviews the recent research progress of CS-based hemostatic hydrogels and their advantageous characteristics compared to traditional hemostatic materials. The effects of the hemostatic mechanism, effects of deacetylation degree, relative molecular mass, and chemical modification on the hemostatic performance of CS hydrogels are summarized. Meanwhile, some typical applications of CS hydrogels are introduced to provide references for the preparation of efficient hemostatic hydrogels. Finally, the future perspectives of CS-based hemostatic hydrogels are presented.
- 13 October 2017
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 67 (13) , 776-782
Paclitaxel-loaded PLA/PEG/fluorescein anticancer agent prepared by Ugi reaction
- 13 October 2017
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 67 (13) , 776-782
Paclitaxel-loaded PLA/PEG/fluorescein anticancer agent prepared by Ugi reaction